.jpeg)
Reckitt has also joined with PATH and the Centre of Health Research and Innovation (CHRI) to start the Dettol Banega Swasth India - Maternal and Child Health Tech Accelerator. This platform creates an opportunity to invite the most innovative ideas o
.jpeg)
Sanofi's approved and pipeline medications aimed at addressing significant care gaps in chronic inflammatory respiratory diseases will be showcased at the European Respiratory Society (ERS) International Congress.
In order to determine whether zilebesiran, an RNAi therapy, might lower the risk of serious adverse cardiovascular events in patients with uncontrolled hypertension, Roche and Alnylam announced their intention to start a Phase III cardiovascular
Aurobindo Pharma announced today that its wholly owned subsidiary Apitoria Pharma received a Form 483 with five observations from the US Food and Drug Administration (FDA). The form was received after the agency performed an inspection of its...
The Food Safety and Standards Authority of India (FSSAI) is planning to release an advisory to restaurants and hotels to include labels in their outlets regarding key ingredients like sugar and oil in their dishes.
Health Minister Damodar Rajanarsimha conducted a review of the performance of the Drugs Control Administration (DCA) and directed officials to initiate action under the PD Act against manufacturers of counterfeit medicines and banned medicines.
Bloodstream infections that come from using catheters in the hospital are common in the ICU in India. They are often caused by germs that fight off drugs
The Food Industry has been requested by the Central Government to maintain ethical standards in food advertisement and labelling for the protection of the public health and consumers' confidence.
BioNTech SE, a worldwide next-generation immunotherapy company, has entered a settlement with CureVac N.V. and GSK plc, and have obtained a non-exclusive license for mRNA-based Covid-19 and influenza products, and have dismissed all ongoing...
.png)
Lupin Limited, an Indian pharmaceutical company situated in Mumbai, has recently launched Glucagon for injection USP, 1 mg/Vial, in America. It is a generic version of Glucagon injection manufactured by Eli Lilly and is contained in an emergency...
, CDSCO.jpg)